Recently, Gu et al. confirmed the role of CETP in breast cancer growth and aggressiveness, suggesting that CETP inhibition might reduce drug resistance by decreasing cholesterol accumulation in breast cancer cells [289]. Here, CETP is linked to breast carcinoma.